John B. Rhodes, Director at Tonix Pharmaceuticals Holding Corp. (TNXP), bought 7,500 shares at $3.33 ($25K) on 2018-06-01, disclosed to the SEC on 2018-06-06.
Open-market purchase of $25k TNXP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |